We’re proud to announce that Hyde Park Capital has been nominated once again for the prestigious Annual M&A Advisor Awards. The deal being recognized this year is the Emerald Coast Infectious Disease, selected in two categories: “Private Equity Deal of the Year” and “Healthcare/Life Sciences Deal of the Year”. Full list of nominees
The M&A Advisor Awards, widely respected as a pinnacle of achievement in the Mergers and Acquisitions industry, recognize excellence in deal-making, restructuring, and financing, celebrating the contributions and achievements of leading firms and professionals. The awards ceremony will be held during the 2023 Future of Dealmaking Summit on November 14-15 in New York City.
Being selected as a finalist is an honor as it is a recognition of the hard work our team put forth in advising Emerald Coast Infectious Disease on its Sale to RCap Equity. Moreover, it shows competency in our team, who advise with excellence on complicated transactions in multiple industries.
About Emerald Coast Infectious Disease
Emerald Coast Infectious Disease, founded 17 years ago by Dr. Patrick Anastasio, is the premier provider of infectious disease care in the Emerald Coast of Florida. ECID specializes in the treatment of diseases such as MRSA, Tuberculosis, HIV/AIDS, HepC, travel health, tropical diseases, and common infections of the skin, lungs, kidneys, bones, and blood. With locations in Fort Walton Beach and Crestview and a new location opening in Panama City Beach, ECID provides a full suite of services to residents along the Florida Panhandle. For additional information, please visit www.infectionclinic.com.
Dr. Patrick Anastasio, Owner and Head Physician of Emerald Coast Infectious Disease, said “I am extremely excited to partner with RCap and take ECID to the next level. With ECID’s exceptional care and RCap’s aptitude for growth, I believe we can become the premier provider of infectious disease care throughout the entire Florida Panhandle.”
Regarding Hyde Park’s services, Dr. Anastasio also said “the Hyde Park Capital team was intricate in finding ECID the best deal. Their professional experience and knowledge helped us navigate through the process, which at times was arduous. Josh, John, and the rest of the HPC team were there with us every step of the way and we would recommend them to any physician practice contemplating a partnership. We are extremely grateful for their services and so glad we chose HPC to be our investment banker.”
About RCap Equity Partners
RCap Equity Partners makes control equity investments and select minority investments in lower middle market companies. The firm is an active investor in profitable and growing enterprises. The RCap team, in partnership with management, seeks to create value through operational improvements, strategic growth initiatives, and acquisitions. More information on RCap and its portfolio companies can be found at www.rcapequity.com.
About M&A Advisor
The M&A Advisor was founded in 1998 to publish insights and intelligence on mergers and acquisitions. Over the past twenty-two years, they have established and now serve the world’s premier organization of M&A, Turnaround, and Finance professionals.
Today, The M&A Advisor is the preeminent organization recognizing excellence, honoring achievement, presenting thought leadership, and facilitating connections among the world’s leading dealmaking professionals.
About Hyde Park Capital
Hyde Park Capital is an institutionally focused boutique investment banking firm specializing in mergers and acquisitions. Hyde Park’s principals have extensive investment banking experience managing merger and acquisition engagements, including executing sell-side and buy-side sales of company assignments, recapitalizations, financial advisory services, fairness opinions, and raising growth capital and acquisition financing for companies, including equity, mezzanine, and senior debt. Hyde Park Capital has extensive experience across numerous industry sectors, including industrial, technology, healthcare, business, and financial services. Hyde Park Capital is headquartered in Tampa, Florida, and is a member of FINRA and SIPC. Hyde Park Capital is also a member of the Geneva Capital Group (GCG) International M&A Alliance. For additional information, please visit www.hydeparkcapital.com.
